当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Ahmet Deniz, Jerry Jaros
The purpose of this study is to give a brief opinion on the usage of opioid analgesics in cancer patients receiving palliative care. Medical staff guidelines for patient education in the treatment of cancer are well-defined, regarded as the most effective, and help to increase treatment compliance. Palliative medicine's major objective is to cure uncomfortable cancer-related symptoms and treatment-related side effects in order to enhance patients' perceived quality of life. Both opiodophobia and the opioid crisis may be alleviated by a strategy that considers the possible risks and advantages of opioid drugs in chronic therapy as well as one-time treatments. The medical profession is more equipped to address the issues of the opioid crisis than the general population, not only by easing its burden but also by supplying, and in some countries restoring, effective pain therapy for cancer patients. In our study, patients also mentioned this when discussing their contacts with pain management specialists. Physician worries stated regarding patient and family unhappiness when opioid analgesics are administered were equivalent to those expressed about administrative challenges and risks of regulatory oversight. However, the population's ageing and the increase in cancer patient life expectancy provide important new obstacles.